Abstract
The news has been full of industry developments and financial investments in
stem cell research in recent weeks. Your company must be aware of the latest
developments immediately.
- Researchers Find New Source For Stem Cells That Could End Debate
- Brain stem cells against cancer?
- ' Bio-ink' Printer Transforms Stem Cells
- US delegation divided over stem cells
Stem cells are without doubt the most controversial area of science at the
moment. The world markets have latched onto the potential offered by stem
cells to modern medicine and, as a result, the research is in the public eye
on an almost daily basis. Are you fully informed of the market potential of
stem cell work? Do you know which companies and research organisations you
must work with now? This report tells you.
So what is all the controversy about? And what products are we likely to see,
in what areas and when, if stem cell work continues at pace?
The potential lies in that given the right circumstances, embryonic stem cells
could be used to create new tissues and organs for patients whose tissues or
organs have been destroyed, damaged, diseased or have simply aged. For
example, for patients with heart failure, the aim would be to create new,
tailor-made cardiac cells to replace the damaged tissue. For patients with
spinal injury, research would be directed at the creation of new spinal tissue
which could replace injured nerve tissue allowing the patient to regain
mobility in paralysed limbs. What part will your company play in this? Find
out today.
However, much of this global effort is currently being thwarted by issues that
are restraining progress in a way that has been unparalleled in the biotech
and pharmaceutical sector. How can your company get around these problems?
What opportunities are there for you? Find out today.
With these obvious frustrations, it is perhaps surprising that so much work on
embryonic stem cells, and to a lesser extent adult stem cells, continues but
governments and companies around the world are evolving new strategies to
overcome these limitations.
One successful product launch will change the face of modern medicine from a
situation where treatments and alleviation of suffering are the norm to one
where replacement parts are offered routinely.
This unique one-stop-shop of a report is the premier business analysis of the
market opportunities. Possible values to the market range from billions to
perhaps nothing. If the one product launch fails to deliver or, worse, has
damaging side-effects, then the market could just as easily collapse
overnight. By reading one report you can put your company to the forefront of
stem cell business knowledge.
This report is a vital addition to gaining an understanding of this highly
profitable market sector and will give your company ' the edge' of your
competitors. You can not afford to be without this report from visiongain.
| 
View Cart
